Welcome to the e-CCO Library!

P374: Therapeutic drug monitoring can guide the intravenous-to-subcutaneous switch of infliximab and vedolizumab: a pharmacokinetic simulation study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wang, Z.(1)*;Verstockt , B.(2,3);Sabino , J.(2,3);Ferrante , M.(2,3);Vermeire , S.(2,3);Dreesen, E.(1);
Created: Friday, 14 July 2023, 11:05 AM
P375 Feasibility of the first paediatric randomised controlled pilot trial of faecal microbiota transplant for ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. PAI2, J. Popov3, E. Hartung1, L. Hill4, K. Grzywacz5, D. Godin5, L. Thabane6, C. Lee7, M. Surette2,8,9, P. Moayyedi2,8

Created: Thursday, 30 January 2020, 10:12 AM
P375: A simulation study to evaluate the performance of a multiple imputation method to address missing data in an analysis of clinical effectiveness using the ImproveCareNow Registry of pediatric patients with Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Zhang, N.(1,2);Liu, C.(1);King, E.(1,2);Chen, S.(1);Olano, K.(1);Steiner, S.(3);Colletti, R.(4);Saeed, S.(5);Strauss, R.(6);Volger, S.(6);Lo, K.H.(6);Wang, Y.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P375: Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn’s disease patients
Year: 2022
Source: ECCO'22
Authors: Revés, J.(1);Morão, B.(1);Gomes, C.F.(1);Nascimento, C.(1);Abreu, N.(2);Gonçalves, T.C.(3);Castro, F.(3);Freitas, M.(3);Moreira, M.J.(3);Cotter, J.(3);Pereira, F.(4);Caldeira, A.(4);Sousa, R.(4);Coelho, R.(5);Macedo, G.(5);Macedo, C.(6);Ferreira, M.(6);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P375: Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multi-centre case series
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. M. Phillips*1, B. Verstockt2,3, S. Sebastian4,5, D. G. Ribaldone6, S. Vavricka7, K. Konstantinos8, E. Slattery9, N. de Suray10,11, C. Flores12, W. Fries13, F. Vincenzi14, E. Capoferro15, O. Bachmann16, U. Kopylov17, ECCO CONFER Investigators1

Created: Friday, 22 February 2019, 9:41 AM
P375: Intraoperative endoscopy is safe and helps to determine the resection extent in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Podmanicky D.*1, Stefanov V.1, Harustiakova D.2, Kovacs J.3, Zelinkova Z.3

Created: Wednesday, 20 February 2019, 10:36 AM
P375: Izencitinib induction treatment in patients with moderately-to-severely-active Crohn's Disease: A phase 2 double-blind, randomized, placebo-controlled study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schreiber, S.(1);Reinisch, W.(2);Nguyen, D.(3);Guerin, T.(4);Kierkus, J.(5);Rozpondek, P.(6);Bourdet, D.(7);Abhyankar, B.(8)*;Peyrin-Biroulet, L.(9);
Created: Friday, 14 July 2023, 11:05 AM
P375: Long-term outcomes after primary infliximab treatment failure in patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Buhl*, C. Steenholdt, M. Borghede, M. Rasmussen, J. Brynskov, O. Ø. Thomsen, M.A. Ainsworth

Created: Friday, 22 February 2019, 9:49 AM
P375: Self-management in inflammatory bowel disease: A perspective of patients and caretakers
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Peek-Kuijt*, S. van den Burg, A. van der Meulen- de Jong, J. Maljaars

Created: Thursday, 21 February 2019, 9:14 AM
P376 Real life health care utilisation in paediatric patients with inflammatory bowel disease in the era of biologics
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S.A. Tchogna, X.Y. Yang, C. Deslandres, P. Jantchou

Created: Thursday, 30 January 2020, 10:12 AM
P376: Assessment of nutritional status and food related experience of adult inflammatory bowel disease inpatients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Keetarut K.*1, Bloom S.2, Qu X.3, Grimble G.3

Created: Wednesday, 20 February 2019, 10:36 AM
P376: Clinical effectiveness of vedolizumab in a tertiary care cohort of IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Bots1*, E. van Baalen2, N. de Boer3, K. Gecse2, C. Ponsioen2, G. D'Haens2, M. Löwenberg2

Created: Thursday, 21 February 2019, 9:14 AM
P376: Effects of IV vedolizumab on health-related quality of life and work productivity in patients with Crohn’s disease: results from the Phase 3b VERSIFY trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Danese1, S. Adsul*2, D. Lindner2, S. Jones3, H. Patel4, J-F. Colombel5

Created: Friday, 22 February 2019, 9:41 AM
P376: Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sands, B.E.(1)*;Jain, A.(2);Ahmad, H.A.(2);Osterman, M.(2);Memaj, A.(2);Canavan, J.B.(2);Axelrad, J.E.(3);
Created: Friday, 14 July 2023, 11:05 AM
P376: Improving stress and fatigue in a real-world setting among patients with Inflammatory Bowel Disease through a digital platform
Year: 2021
Source: ECCO'21 Virtual
Authors: Oddsson, S.(1);Gunnarsdottir, T.(1);Johannsdottir, L.(2);Amundadottir, M.(3);Frimannsdottir, A.(3);Ylanne, K.(4);Molander, P.(5);Islind, A.(2);Oskarsdottir, M.(2);Thorgeirsson, T.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P376: Switching from intravenous to subcutaneous vedolizumab maintenance treatment; feasibility, safety and clinical outcome
Year: 2022
Source: ECCO'22
Authors: Wiken, T.(1,2);Høivik, M.L.(1,2);Buer, L.(1);Bolstad, N.(3);Moum, B.A.(1,2);Medhus, A.W.(1);
Created: Friday, 11 February 2022, 3:52 PM
P376: Therapy refractory ulcerative colitis patients may benefit from appendectomy: early result from the PASSION study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Sahami*1, C. Buskens1, D. Winter2, S. Martin2, P. Tanis1, G. van den Brink3, M. Löwenberg3, G. Cullen4, H. Mulcahy4, G. Doherty4, C. Ponsioen3, G. D’Haens3, W. Bemelman1

Created: Friday, 22 February 2019, 9:49 AM
P377 Risk factors of rectal amputation for Crohn’s disease with perianal lesion
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Yokoo, S. Yoshikawa, T. Masuda, H. Uchida, T. Nakao, H. Kashizuka, K. Yamaoka, M. Inagaki, K. Okamoto, N. Inatsugi

Created: Thursday, 30 January 2020, 10:12 AM
P377: Changes over time in the Lémann Index and the Inflammatory Bowel Disease-Disability Index in patients with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wils, P.(1)*;Cartier, L.(2);Azahaf, M.(3);Hambli, S.(1);Branche, J.(1);Gérard, R.(1);Desreumaux, P.(1);Louvet, A.(1);Nachury, M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P377: Clinical strategies based on patient-reported outcomes and physicians’ preferences to monitor biological therapy in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Risager Christensen*1, C. Steenholdt1, S. Buhl Næss-Schmidt1, J. Brynskov1, M. A. Ainsworth1,2

Created: Friday, 22 February 2019, 9:41 AM